Cell Free Preimplantation Genetic Testing
Launched by GENOMIC PREDICTION INC. · Nov 9, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving genetic testing for embryos during in vitro fertilization (IVF). The researchers want to see if they can safely and accurately test for genetic information using the fluid that embryos grow in, instead of taking a tiny sample directly from the embryo itself. This new method, called cell-free preimplantation genetic testing, will be compared to the traditional approach where a small biopsy is taken from the embryo.
To participate in this study, patients who are planning to undergo IVF and are interested in the LifeView genetic testing will be eligible. There are no specific exclusions, meaning that anyone who meets the inclusion criteria can consider joining. If you take part in this study, you can expect to contribute to important research that may help improve fertility treatments in the future. The trial is currently not recruiting participants, so you would need to wait until it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing IVF electing to utilize LifeView testing (PGT) will be offered participation in this study.
- Exclusion Criteria:
- • None
About Genomic Prediction Inc.
Genomic Prediction Inc. is a leading biotechnology company specializing in advanced genomic technologies aimed at enhancing precision medicine and reproductive health. The organization focuses on leveraging cutting-edge genetic testing and predictive analytics to empower individuals and healthcare providers with actionable insights into genetic risks and health outcomes. By integrating sophisticated algorithms and extensive genomic databases, Genomic Prediction Inc. strives to facilitate informed decision-making in clinical settings, ultimately improving patient care and outcomes through personalized approaches to health management and disease prevention.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
North Brunswick, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials